Medicine Description marvitense 40/5/25 mg
marvitense 40/5/25 mg tablets is a medication that combines three active ingredients: amlodipine, hydrochlorothiazide, and olmesartan. Amlodipine is a calcium channel blocker that works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to relaxation of the blood vessels and a decrease in blood pressure. Hydrochlorothiazide is a diuretic that promotes the excretion of sodium and water from the kidneys, effectively reducing blood volume and contributing to lower blood pressure. Olmesartan, an angiotensin II receptor blocker (ARB), prevents angiotensin II from binding to its receptors, which helps to relax blood vessels and further reduce blood pressure. Together, these three agents provide a synergistic effect, enhancing the overall management of hypertension and improving cardiovascular health.
Indications and Uses of marvitense 40/5/25 mg tablets
- Management of essential hypertension
- Reduction of the risk of cardiovascular events in patients with hypertension
- Management of fluid retention in certain patients
Side Effects of marvitense 40/5/25 mg tablets
- Dizziness or lightheadedness
- Fatigue
- Swelling in the ankles or feet
- Headaches
- Gastrointestinal disturbances (nausea, diarrhea)
- Increased potassium levels in the blood
Storage and Handling
Store marvitense 40/5/25 mg tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and do not use it after the expiration date.
Patient Advice and Precautions
Patients should be advised to monitor their blood pressure regularly and report any significant changes or symptoms such as severe dizziness or swelling. It's important to maintain adequate hydration and inform healthcare providers of all medications being taken to avoid potential drug interactions. Regular follow-ups with a healthcare provider are recommended to assess the efficacy and safety of the treatment.